Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid cream to prevent post-inflammatory hyperpigmentation after Q-switched ruby laser
jRCT1030200265Completed
- Sponsor
- JMEC
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tranexamic acid in actinic lentigo and Post-inflammatory hyperpigmentation (PIH), sponsored by JMEC. Started Dec 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
actinic lentigoPost-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on jRCT1030200265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030200265.